• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Latexin (LXN)

ACP18923

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP18923 Target NameLXN
Target SynonymsECI; Endogenous carboxypeptidase inhibitor; Latexin; Latexin protein; LXN; LXN_HUMAN; MUM; Protein MUM; TCI; Tissue carboxypeptidase inhibitorFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-222
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9BS40
Background Information
  • Uniprot Id

    Q9BS40

  • Target Species

    Human

  • Target Name

    LXN

  • Target Full Name

    Latexin

  • Target Function

    Hardly reversible, non-competitive, and potent inhibitor of CPA1, CPA2 and CPA4. May play a role in inflammation.

  • Target Subcellular Location

    Cytoplasm.

  • Target Protein Families

    Protease inhibitor I47 (latexin) family

  • Target Tissue Specificity

    Highly expressed in heart, prostate, ovary, kidney, pancreas, and colon, moderate or low in other tissues including brain.

  • Target Synonyms

    ECI; Endogenous carboxypeptidase inhibitor; Latexin; Latexin protein; LXN; LXN_HUMAN; MUM; Protein MUM; TCI; Tissue carboxypeptidase inhibitor

Inquire Recombinant Human Latexin (LXN) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification